UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial

European journal of cancer (1990), 2004-05, Vol.40 (7), p.988-997

2004

Link zum Volltext

Verfügbarkeit prüfen

Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer

Oncology, 2006-05, Vol.70 (2), p.141-146

2006

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy

Supportive care in cancer, 1999-09, Vol.7 (5), p.354-361

1999

Link zum Volltext

Verfügbarkeit prüfen

Extended phase II study of paclitaxel as a 3-h infusion in patients with ovarian cancer previously treated with platinum

European journal of cancer (1990), 1997-03, Vol.33 (3), p.379-384

1997

Link zum Volltext

Verfügbarkeit prüfen

Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron

European journal of cancer (1990), 1992, Vol.28 (2), p.450-457

1992

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelial ovarian cancer

Annals of oncology, 1997-04, Vol.8 (4), p.355-361

1997

Link zum Volltext

Verfügbarkeit prüfen

Clinical phase I study with one-hour paclitaxel infusion

Annals of oncology, 1998-05, Vol.9 (5), p.569-572

1998

Link zum Volltext

Verfügbarkeit prüfen

Randomized Study Comparing Carboplatin/Cyclophosphamide and Cisplatin/Cyclophosphamide as First-Line Treatment in Patients with Stage III/IV Epithelial Ovarian Cancer and Small Volume Disease

Gynecologic oncology, 1997-07, Vol.66 (1), p.75-84

1997

Link zum Volltext

Verfügbarkeit prüfen

Combination paclitaxel (Taxol®)–carboplatin as first‐line therapy for advanced ovarian cancer

International journal of gynecological cancer, 1997-05, Vol.7 (s1), p.18-22

MEERPOHL, H. G.

1997

Link zum Volltext

Verfügbarkeit prüfen

Positron emission tomography helps to diagnose tumor emboli and residual disease in choriocarcinoma

Annals of oncology, 1996-04, Vol.7 (4), p.416-418

1996

Link zum Volltext

Verfügbarkeit prüfen

HPV-Detektion in Sentinellymphknoten bei Patientinnen mit Zervixkarzinom

Geburtshilfe und Frauenheilkunde, 2003, Vol.63 (12)

2003

Link zum Volltext

Verfügbarkeit prüfen

Pathophysiology, severity, pattern, and risk factors for carboplatin-induced emesis

Oncology, 1996-01, Vol.53 Suppl 1, p.46

1996

Link zum Volltext

Verfügbarkeit prüfen

Paclitaxel-Induced “Recall” Soft Tissue Ulcerations Occurring at the Site of Previous Subcutaneous Administration of Paclitaxel in Low Doses

Gynecologic oncology, 1996-01, Vol.60 (1), p.94-96

1996

Link zum Volltext

Verfügbarkeit prüfen

The role of serotonin as a mediator of emesis induced by different stimuli

Supportive care in cancer, 1995-09, Vol.3 (5), p.285-290

1995

Link zum Volltext

Verfügbarkeit prüfen

Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer

Seminars in oncology, 1996-02, Vol.23 (1 Suppl 1), p.33

1996

Link zum Volltext

Verfügbarkeit prüfen

Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer

Seminars in oncology, 1995-12, Vol.22 (6 Suppl 15), p.7

1995

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the Emetogenic Potential Between Cisplatin and Carboplatin in Combination with Alkylating Agents

Acta oncologica, 1994, Vol.33 (5), p.531-535

1994

Link zum Volltext

Verfügbarkeit prüfen

Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer

Seminars in oncology, 1997-02, Vol.24 (1 Suppl 3), p.S13

1997

Link zum Volltext

Verfügbarkeit prüfen

Combined radio‐chemotherapy in advanced cervical cancer: a phase‐II trial with weekly applied carboplatin, 5‐fluorouracil and folinic acid

International journal of gynecological cancer, 1996-01, Vol.6 (1), p.20-26

1996

Link zum Volltext

Verfügbarkeit prüfen

Standard of chemotherapy in ovarian cancer

Chirurg, 1994-01, Vol.65 (1), p.18

1994

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of pirarubicin combined with cisplatin in recurrent ovarian cancer

Journal of cancer research and clinical oncology, 1994-01, Vol.120 (3), p.173-178

1994

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of carboplatin/ifosfamide in untreated advanced cervical cancer

Cancer chemotherapy and pharmacology, 1990, Vol.26 (S1), p.S33-S35

1990

Link zum Volltext

Verfügbarkeit prüfen

Role of prostaglandins on the regulation of macrophage proliferation and cytotoxic functions

Prostaglandins, 1986-05, Vol.31 (5), p.961-972

1986

Link zum Volltext

Verfügbarkeit prüfen

Studies on the activation of mouse bone marrow‐derived macrophages by the macrophage cytotoxicity factor (MCF)

European journal of immunology, 1976-03, Vol.6 (3), p.213-217

1976

Link zum Volltext

Verfügbarkeit prüfen

Formation of prostaglandins by ovarian carcinomas

Prostaglandins, 1985-05, Vol.29 (5), p.665-672

1985

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(29)
Tagungsberichte
(1)

Sprache

Englisch
(28)
Deutsch
(3)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial

Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer

Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy

Extended phase II study of paclitaxel as a 3-h infusion in patients with ovarian cancer previously treated with platinum

Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: a study with ondansetron

Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelial ovarian cancer

Clinical phase I study with one-hour paclitaxel infusion

Randomized Study Comparing Carboplatin/Cyclophosphamide and Cisplatin/Cyclophosphamide as First-Line Treatment in Patients with Stage III/IV Epithelial Ovarian Cancer and Small Volume Disease

Combination paclitaxel (Taxol®)–carboplatin as first‐line therapy for advanced ovarian cancer

Positron emission tomography helps to diagnose tumor emboli and residual disease in choriocarcinoma

HPV-Detektion in Sentinellymphknoten bei Patientinnen mit Zervixkarzinom

Pathophysiology, severity, pattern, and risk factors for carboplatin-induced emesis

Paclitaxel-Induced “Recall” Soft Tissue Ulcerations Occurring at the Site of Previous Subcutaneous Administration of Paclitaxel in Low Doses

The role of serotonin as a mediator of emesis induced by different stimuli

Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer

Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer

Comparison of the Emetogenic Potential Between Cisplatin and Carboplatin in Combination with Alkylating Agents

Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer

Combined radio‐chemotherapy in advanced cervical cancer: a phase‐II trial with weekly applied carboplatin, 5‐fluorouracil and folinic acid

Standard of chemotherapy in ovarian cancer

Phase II study of pirarubicin combined with cisplatin in recurrent ovarian cancer

Phase II study of carboplatin/ifosfamide in untreated advanced cervical cancer

Role of prostaglandins on the regulation of macrophage proliferation and cytotoxic functions

Studies on the activation of mouse bone marrow‐derived macrophages by the macrophage cytotoxicity factor (MCF)

Formation of prostaglandins by ovarian carcinomas

Suchergebnisse filtern